| 1 |
Wang X, Wang Y, Xue Z, Wan W, Li Y, Qin H, Zhu Y, Tian F, Yang J. Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment. J Colloid Interface Sci 2023;636:388-400. [PMID: 36640550 DOI: 10.1016/j.jcis.2023.01.007] [Reference Citation Analysis]
|
| 2 |
Ye E, Park E, Kim E, Lee JE, Yang SH, Park S. Transcranial application of magnetic pulses for improving brain drug delivery efficiency via intranasal injection of magnetic nanoparticles. Biomed Eng Lett 2023. [DOI: 10.1007/s13534-023-00272-0] [Reference Citation Analysis]
|
| 3 |
Orita Y, Shimanuki S, Okada S, Nakamura K, Nakamura H, Kitamoto Y, Shimoyama Y, Kurashina Y. Acoustic-responsive carbon dioxide-loaded liposomes for efficient drug release. Ultrason Sonochem 2023;94:106326. [PMID: 36796146 DOI: 10.1016/j.ultsonch.2023.106326] [Reference Citation Analysis]
|
| 4 |
Liu Z, Ren X, Huang Y, Sun J, Wang X, Zheng M, Cui L, Zhang X, Tang Z. A Novel CA4P Polymeric Nanoparticle for Murine Hepatoma Therapy. Chin J Polym Sci 2023. [DOI: 10.1007/s10118-023-2921-7] [Reference Citation Analysis]
|
| 5 |
Curcio A, Perez JE, Prévéral S, Fromain A, Genevois C, Michel A, Van de Walle A, Lalatonne Y, Faivre D, Ménager C, Wilhelm C. The role of tumor model in magnetic targeting of magnetosomes and ultramagnetic liposomes. Sci Rep 2023;13:2278. [PMID: 36755030 DOI: 10.1038/s41598-023-28914-4] [Reference Citation Analysis]
|
| 6 |
Zhao Z, Saiding Q, Cai Z, Cai M, Cui W. Ultrasound technology and biomaterials for precise drug therapy. Materials Today 2023. [DOI: 10.1016/j.mattod.2022.12.004] [Reference Citation Analysis]
|
| 7 |
Curcio A, Perez JE, Prévéral S, Fromain A, Genevois C, Michel A, de Walle AV, Lalatonne Y, Faivre D, Ménager C, Wilhelm C. The role of tumor model in magnetic targeting of magnetosomes and ultramagnetic liposomes.. [DOI: 10.21203/rs.3.rs-2317102/v1] [Reference Citation Analysis]
|
| 8 |
Zhang F, Xia B, Sun J, Wang Y, Wang J, Xu F, Chen J, Lu M, Yao X, Timashev P, Zhang Y, Chen M, Che J, Li F, Liang X. Lipid-Based Intelligent Vehicle Capabilitized with Physical and Physiological Activation. Research 2022;2022:1-21. [DOI: 10.34133/2022/9808429] [Reference Citation Analysis]
|
| 9 |
Farjadian F, Ghasemi S, Akbarian M, Hoseini-ghahfarokhi M, Moghoofei M, Doroudian M. Physically stimulus-responsive nanoparticles for therapy and diagnosis. Front Chem 2022;10:952675. [DOI: 10.3389/fchem.2022.952675] [Reference Citation Analysis]
|
| 10 |
Ashrafizadeh M, Delfi M, Zarrabi A, Bigham A, Sharifi E, Rabiee N, Paiva-Santos AC, Kumar AP, Tan SC, Hushmandi K, Ren J, Zare EN, Makvandi P. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches. J Control Release 2022:S0168-3659(22)00481-3. [PMID: 35934254 DOI: 10.1016/j.jconrel.2022.08.001] [Reference Citation Analysis]
|
| 11 |
De Leo V, Maurelli AM, Giotta L, Catucci L. Liposomes containing nanoparticles: preparation and applications. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
Jiang XC, Zhang T, Gao JQ. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Adv Drug Deliv Rev 2022;187:114324. [PMID: 35640803 DOI: 10.1016/j.addr.2022.114324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 13 |
Ribeiro TP, Moreira JA, Monterio FJ, Laranjeira MS. Nanomaterials in cancer: Reviewing the combination of hyperthermia and triggered chemotherapy. J Control Release 2022:S0168-3659(22)00240-1. [PMID: 35513211 DOI: 10.1016/j.jconrel.2022.04.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Liu Z, Zhang Y, Shen N, Sun J, Tang Z, Chen X. Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect. Adv Drug Deliv Rev 2022;183:114138. [PMID: 35143895 DOI: 10.1016/j.addr.2022.114138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Difonzo M, Fliedel L, Mignet N, Andrieux K, Alhareth K. How Could Nanomedicine Improve the Safety of Contrast Agents for MRI during Pregnancy? Sci 2022;4:11. [DOI: 10.3390/sci4010011] [Reference Citation Analysis]
|
| 16 |
Low LE, Lim HP, Ong YS, Siva SP, Sia CS, Goh B, Chan ES, Tey BT. Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Banerjee RK, Chandran NT, Paruchuri SS, Myers MR. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ENERGIZED NANOPARTICLES-MEDIATED ENHANCED THERMAL ABLATION OF TUMORS: REVIEW OF RECENT PROGRESS AND A PROPOSED METHODOLOGY FOR DISTINGUISHING HEAT SOURCES. Annual Rev Heat Transfer 2022;24:435-461. [DOI: 10.1615/annualrevheattransfer.2022042051] [Reference Citation Analysis]
|
| 18 |
Gültekin HE, Oner E, İlhan M, Karpuz M. Nanovesicles for intravenous drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00018-3] [Reference Citation Analysis]
|
| 19 |
Józefczak A, Kaczmarek K, Bielas R. Magnetic mediators for ultrasound theranostics. Theranostics 2021;11:10091-113. [PMID: 34815806 DOI: 10.7150/thno.62218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Ang MJY, Chan SY, Goh YY, Luo Z, Lau JW, Liu X. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics. Adv Drug Deliv Rev 2021;178:113907. [PMID: 34371084 DOI: 10.1016/j.addr.2021.113907] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 21 |
Wood CA, Han S, Kim CS, Wen Y, Sampaio DRT, Harris JT, Homan KA, Swain JL, Emelianov SY, Sood AK, Cook JR, Sokolov KV, Bouchard RR. Clinically translatable quantitative molecular photoacoustic imaging with liposome-encapsulated ICG J-aggregates. Nat Commun 2021;12:5410. [PMID: 34518530 DOI: 10.1038/s41467-021-25452-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 22 |
Tehrani Fateh S, Moradi L, Kohan E, Hamblin MR, Shiralizadeh Dezfuli A. Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications. Beilstein J Nanotechnol 2021;12:808-62. [PMID: 34476167 DOI: 10.3762/bjnano.12.64] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 23 |
Tran VL, Lux F, Tournier N, Jego B, Maître X, Anisorac M, Comtat C, Jan S, Selmeczi K, Evans MJ, Tillement O, Kuhnast B, Truillet C. Quantitative Tissue Pharmacokinetics and EPR Effect of AGuIX Nanoparticles: A Multimodal Imaging Study in an Orthotopic Glioblastoma Rat Model and Healthy Macaque. Adv Healthc Mater 2021;10:e2100656. [PMID: 34212539 DOI: 10.1002/adhm.202100656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Salerno A, Netti PA. Review on Computer-Aided Design and Manufacturing of Drug Delivery Scaffolds for Cell Guidance and Tissue Regeneration. Front Bioeng Biotechnol 2021;9:682133. [PMID: 34249885 DOI: 10.3389/fbioe.2021.682133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 25 |
Musielak M, Potoczny J, Boś-Liedke A, Kozak M. The Combination of Liposomes and Metallic Nanoparticles as Multifunctional Nanostructures in the Therapy and Medical Imaging-A Review. Int J Mol Sci 2021;22:6229. [PMID: 34207682 DOI: 10.3390/ijms22126229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Sang R, Stratton B, Engel A, Deng W. Liposome technologies towards colorectal cancer therapeutics. Acta Biomater 2021;127:24-40. [PMID: 33812076 DOI: 10.1016/j.actbio.2021.03.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Liu L, O'Kelly D, Schuetze R, Carlson G, Zhou H, Trawick ML, Pinney KG, Mason RP. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 2021;26:2551. [PMID: 33925707 DOI: 10.3390/molecules26092551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Veloso SRS, Andrade RGD, Castanheira EMS. Magnetoliposomes: recent advances in the field of controlled drug delivery. Expert Opin Drug Deliv 2021;:1-12. [PMID: 33836636 DOI: 10.1080/17425247.2021.1915983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Mai X, Chang Y, You Y, He L, Chen T. Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation. Journal of Controlled Release 2021;331:270-81. [DOI: 10.1016/j.jconrel.2020.09.051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 30 |
Zhao D, Huang X, Zhang Z, Ding J, Cui Y, Chen X. Engineered nanomedicines for tumor vasculature blockade therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1691. [PMID: 33480163 DOI: 10.1002/wnan.1691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Ahmadi A, Hosseini-Nami S, Abed Z, Beik J, Aranda-Lara L, Samadian H, Morales-Avila E, Jaymand M, Shakeri-Zadeh A. Recent advances in ultrasound-triggered drug delivery through lipid-based nanomaterials. Drug Discov Today 2020;25:2182-200. [PMID: 33010479 DOI: 10.1016/j.drudis.2020.09.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 32 |
Pecyna P, Wargula J, Murias M, Kucinska M. More Than Resveratrol: New Insights into Stilbene-Based Compounds. Biomolecules 2020;10:E1111. [PMID: 32726968 DOI: 10.3390/biom10081111] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 33 |
Pecyna P, Wargula J, Murias M, Kucinska M. More Than Resveratrol: New Insights into Stilbene-Based Compounds. Biomolecules 2020;10:E1111. [PMID: 32726968 DOI: 10.3390/biom10081111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
